Filter Results:
(3,381)
Show Results For
- All HBS Web
(3,381)
- People (9)
- News (695)
- Research (2,163)
- Events (34)
- Multimedia (26)
- Faculty Publications (1,256)
Show Results For
- All HBS Web
(3,381)
- People (9)
- News (695)
- Research (2,163)
- Events (34)
- Multimedia (26)
- Faculty Publications (1,256)
- 19 Aug 2016
- News
Lending a Hand to Small Businesses in Emerging Markets
In emerging markets, where traditional credit scores are rare, how can lenders decide who is creditworthy? Just ask, says DJ DiDonna (MBA 2010), cofounder and chief strategy officer of the for-profit Entrepreneurial Finance Lab. The company has developed a 20- to... View Details
- March 2016 (Revised March 2022)
- Teaching Note
Evive Health and Workplace Influenza Vaccinations
By: John Beshears
Evive Health is a company that manages communication campaigns on behalf of health insurance plans and large employers. Using big data techniques and insights from behavioral economics, Evive deploys targeted and effective messages that improve individuals' health... View Details
Keywords: Vaccination; Influenza; Flu Shot; Preventive Care; Health Care; Behavioral Economics; Choice Architecture; Nudge; Experimental Design; Randomized Controlled Trial; RCT; Causal Inference; Health Care and Treatment; Insurance; Health; Consumer Behavior; Health Testing and Trials; Communication Strategy; Insurance Industry; Health Industry
- Profile
Eric Sonnier
industries, including oil, telecom, and retail. Then Eric became interested in entrepreneurship. “I wasn’t sure it was right for me, but you don’t know until you test it,” Eric says. “I went from the largest professional-services company... View Details
- Profile
Mike Monagle
business and then moved into a strategic role managing company interests in Asia. As it became clearer that Mike wanted to build a business of his own, he recognized a need to expand his skills and “reflect on my future,” he says. “In the right program, I could View Details
- 11 Dec 2014
- News
Revolutionizing digital medical records
coordinated, and lower-cost care. Bushkin expects MedKaz to revolutionize health care, bringing about changes in care quality and facilitating changes in the way care is delivered. With it, doctors can avoid medical mistakes and unnecessary View Details
- December 2023 (Revised March 2024)
- Case
Manufacturing Moderna's Future
By: Satish Tadikonda and William Marks
In 2019, Moderna faced long odds of survival having failed to develop a successful clinical program out of the vast platform technology they had built around mRNA. Nearly overnight, the company skyrocketed to success with a vaccine for COVID-19, leading to an extremely... View Details
Keywords: Health Pandemics; Health Testing and Trials; Technological Innovation; Product Development; Production; Science-Based Business; Biotechnology Industry
Tadikonda, Satish, and William Marks. "Manufacturing Moderna's Future." Harvard Business School Case 824-076, December 2023. (Revised March 2024.)
- 12 Nov 2015
- Research & Ideas
Can Consumers be Trusted with Their Own Health Care?
and a profile that varies by situation and according to the patient’s life stage.” Patient Empowerment Taken Too Far? As an example of patient empowerment—and a glimpse at its potential problems—Quelch talked about taking the 23andMe test, a saliva-based... View Details
- Web
Day in IFC: Marta Milkowska (HKS), United Kingdom - MBA
750 pages of interviews with subject matter experts in journal articles, academic papers, books, and other literature. In January 2017, our team spent ten days working with BI Ventures to design a "rainy day savings" intervention plan. The following photos showcase a... View Details
- 01 Sep 2012
- News
Start It Up
which manufactures solar-paneled generators that require only minimal diesel to help recharge their batteries. In Iraq, “I’d see huge generators running all the time but powering very little,” Moorehead said. “We take it from running 24 hours down to 4 or 5 hours a... View Details
- 01 Mar 2016
- News
Off Script
(Thinkstock) Prescription drug spending increased by more than 13 percent in the United States in 2014, raising health insurance premiums and the ire of consumers and politicians. The reasons behind the rise are many, including the high cost of drug development—as much... View Details
- 22 Jan 2001
- Research & Ideas
Control Your Inventory in a World of Lean Retailing
manufacturer can increase profits and reduce inventory risks. To demonstrate that improvement, we ran a computer simulation that tests various inventory policies for three groups of SKUs in the same product line — one group with low... View Details
- 15 Aug 2006
- First Look
First Look: August 15, 2006
financial markets change the interaction between banks and corporations? This paper compares the importance of interlocking boards of directors between corporations and banks in Brazil, Mexico, and the United States circa 1909. The hypothesis View Details
Keywords: Sean Silverthorne
- February 2020
- Teaching Note
Theranos: Who Has Blood on Their Hands? (A) and (B)
By: Nien-he Hsieh and Christina R. Wing
Teaching Note for HBS Nos. 619-039 and 320-091. View Details
- November 2009 (Revised March 2010)
- Case
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details
Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States
Hamermesh, Richard G., Raju Kucherlapati, and Rachel Gordon. "Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story." Harvard Business School Case 810-066, November 2009. (Revised March 2010.)
- Web
Success Academy Charter Schools | Information Technology
and Research ; Senior Associate Dean for Faculty Development and Research test caption Previous test caption Previous Next test caption Previous Next More Featured Cases Lupoli... View Details
- 2023
- Working Paper
Market Exclusivity and Innovation: Evidence From Antibiotics
By: Edward Kong and Olivia Zhao
The US incentivizes drug innovation via patents as well as market exclusivity periods awarded by the US Food and Drug Administration. We estimate the causal effects of extending market exclusivity for an important drug class: antibiotics. Using a... View Details
Keywords: Health Testing and Trials; Innovation and Invention; Motivation and Incentives; Government Administration; Government Legislation; Pharmaceutical Industry; United States
Kong, Edward, and Olivia Zhao. "Market Exclusivity and Innovation: Evidence From Antibiotics." Working Paper, December 2023.
- Web
Sponsors | New Venture Competition
Sponsors The New Venture Competition thanks its sponsors for their tremendous support which enables participants to access expert resources, test their ideas, and gain real-world feedback throughout the process. Amazon Web Services All... View Details
- 31 Jan 2016
- News
Studios Back App, Hoping to Fill Cinema Seats
to keep testing it,” said Mr. Bakal, adding that variable pricing won't be among the company’s offerings when it launches nationwide. Atom Tickets has been operating in three test markets since April, where... View Details
- 01 Jun 1996
- News
GMAT Added to Admissions Criteria
In April, Dean Kim B. Clark announced that Harvard Business School will add the Graduate Management Admissions Test (GMAT) to the portfolio of criteria used to evaluate a candidate's application to the MBA Program, effective for... View Details
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.